GAFA
BSX icon

Garton & Associates Financial Advisors’s Boston Scientific BSX Stock Holding History

Garton & Associates Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-277
Closed -$26.4K – 200
2025
Q4 		$26.4K Buy
+277
New +$27.2K 0.01% 544

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garton & Associates Financial Advisors's BSX Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 277 shares — an estimated $26.4K sold.

Garton & Associates Financial Advisors first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $26.4K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 277 Boston Scientific shares in Q1 2026, an estimated $26.4K.
  • Garton & Associates Financial Advisors first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Boston Scientific position peaked at $26.4K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.